Stock TRML TOURMALINE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Tourmaline Bio, Inc.

Equities

TRML

US89157D1054

Market Closed - Nasdaq
Other stock markets
 01:30:00 29/06/2024 am IST 		5-day change 1st Jan Change
12.86 USD -2.80% Intraday chart for Tourmaline Bio, Inc. -15.95% -50.88%
27/06 Tourmaline Bio Names Interim CFO Ryan Robinson as Permanent Finance Chief MT
27/06 Tourmaline Bio, Inc. Announces the Promotion of Ryan Robinson to Chief Financial Officer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
TOURMALINE BIO, INC. Stock Tourmaline Bio, Inc.
 330M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 113B
ARGENX SE Stock argenx SE
 26.02B -
BIONTECH SE Stock BioNTech SE
 19.39B -
GENMAB A/S Stock Genmab A/S
 15.91B
  1. Stock Market
  2. Equities
  3. TRML Stock
  4. Charts Tourmaline Bio, Inc.
  5. Sector Chart